Key Position Statements
Transplantation is a rapidly advancing field; it is important to provide accurate information to federal decision-makers and their staff. Therefore, the AST Board of Directors seeks input from its committees and Communities of Practice to develop key position statements that address these important issues.
- Access to Kidney Transplantation for Patients with End-Stage Kidney Disease (ESKD)
- Antimicrobial Resistance and Human Use of Antibiotics
- Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act Opposition
- Candidate Selection for Transplantation
- Comprehensive Living Organ Donor Protections
- Conflict of Interest in Medical Research, Education and Practice
- Deceased Organ Donation
- Immunosuppressive Drug Coverage Under Medicare Part B
- Immunosuppressant Drug Coverage Under Medicare Part D
- Insurance Coverage for Transplant Recipients
- Joint AST-ASTS-AAKP Statement of Policy Principles and Solutions: Living Organ Donation
- Living Organ Donation
- Metrics for Patient Education and Referral to Kidney Transplant in Dialysis Centers
- NIH Study Section Dedicated to Transplantation Research
- Normothermic Regional Perfusion (NRP)
- Organ Trafficking and Transplant Tourism
- Organ Procurement & Transplantation Network (OPTN) Modernization
- Pediatrics
- Racial Bias in Clinical Tools and Impact on Organ Transplantation
- Reaffirmation of AST's Commitment to Diversity, Equity, Inclusion, and Belonging
- Research/NIH Funding
- Research on the Apolipoprotein L1 (APOL1) Gene and its Impact on African Americans
- Statement on Supreme Court's Overturning of Roe v. Wade
- Transplantation of Organs from HIV-infected Donors (HOPE Act)
- Transplantation of Hepatitis C-Viremic Donor Organs into Hepatitis C Uninfected Recipients
- A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
- Vascularized Composite Allotransplantation (VCA) Research